Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.3%

18 terminated/withdrawn out of 146 trials

Success Rate

76.3%

-10.2% vs industry average

Late-Stage Pipeline

14%

20 trials in Phase 3/4

Results Transparency

5%

3 of 58 completed trials have results

Key Signals

18 recruiting3 with results11 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
48(52.2%)
Phase 1
12(13.0%)
Phase 2
11(12.0%)
Phase 4
10(10.9%)
Phase 3
10(10.9%)
Early Phase 1
1(1.1%)
92Total
N/A(48)
Phase 1(12)
Phase 2(11)
Phase 4(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (146)

Showing 20 of 146 trials
NCT04261972Active Not Recruiting

Cell-free DNA in Hereditary And High-Risk Malignancies 1

Role: collaborator

NCT07292142Phase 1Not Yet Recruiting

FMT in Triple Negative Breast Cancer Guided by ctDNA

Role: lead

NCT06726642Recruiting

CfDNA in Hereditary And High-risk Malignancies 2

Role: collaborator

NCT04874064Recruiting

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

Role: lead

NCT05719415Not ApplicableRecruiting

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

Role: lead

NCT06701929Recruiting

The Impact of Fasting Duration on Quality of Recovery After Cesarean Section

Role: lead

NCT05000138Completed

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

Role: lead

NCT02330926Phase 3Completed

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Role: collaborator

NCT03671967Phase 4Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Role: collaborator

NCT07095192Recruiting

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

Role: collaborator

NCT01309490Phase 1Terminated

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Role: lead

NCT05007015Not ApplicableActive Not Recruiting

Transanal Irrigation for the Management of LARS

Role: lead

NCT05347238Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Role: collaborator

NCT04178174Phase 3Recruiting

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Role: collaborator

NCT02840149Phase 3Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Role: lead

NCT03461497Active Not Recruiting

Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery

Role: collaborator

NCT05785065Phase 2Recruiting

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Role: collaborator

NCT03957434Not ApplicableActive Not Recruiting

Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence

Role: collaborator

NCT05188222Phase 4Not Yet Recruiting

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Role: lead

NCT04671511Not ApplicableRecruiting

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

Role: lead